Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation

Emily H Pilkington, May Lai, Xinwei Ge, William J Stanley, Bo Wang, Miaoyi Wang, Aleksandr Kakinen, Mark-Antoine Sani, Michael R Whittaker, Esteban N. Gurzov, Feng Ding, John Quinn, Thomas P Davis, Pu Chun Ke

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Protein aggregation into amyloid fibrils is a ubiquitous phenomenon across the spectrum of neurodegenerative disorders and type 2 diabetes. A common strategy against amyloidogenesis is to minimize the populations of toxic oligomers and protofibrils by inhibiting protein aggregation with small molecules or nanoparticles. However, melanin synthesis in nature is realized by accelerated protein fibrillation to circumvent accumulation of toxic intermediates. Accordingly, we designed and demonstrated the use of star-shaped poly(2-hydroxyethyl acrylate) (PHEA) nanostructures for promoting aggregation while ameliorating the toxicity of human islet amyloid polypeptide (IAPP), the peptide involved in glycemic control and the pathology of type 2 diabetes. The binding of PHEA elevated the β-sheet content in IAPP aggregates while rendering a new morphology of "stelliform" amyloids originating from the polymers. Atomistic molecular dynamics simulations revealed that the PHEA arms served as rodlike scaffolds for IAPP binding and subsequently accelerated IAPP aggregation by increased local peptide concentration. The tertiary structure of the star nanoparticles was found to be essential for driving the specific interactions required to impel the accelerated IAPP aggregation. This study sheds new light on the structure-toxicity relationship of IAPP and points to the potential of exploiting star polymers as a new class of therapeutic agents against amyloidogenesis.

Original languageEnglish
Pages (from-to)4249-4260
Number of pages12
JournalBiomacromolecules
Volume18
Issue number12
DOIs
Publication statusPublished - 11 Dec 2017

Cite this

Pilkington, Emily H ; Lai, May ; Ge, Xinwei ; Stanley, William J ; Wang, Bo ; Wang, Miaoyi ; Kakinen, Aleksandr ; Sani, Mark-Antoine ; Whittaker, Michael R ; Gurzov, Esteban N. ; Ding, Feng ; Quinn, John ; Davis, Thomas P ; Ke , Pu Chun . / Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation. In: Biomacromolecules. 2017 ; Vol. 18, No. 12. pp. 4249-4260.
@article{f035fd3aaaff42c09f4f8507c8e6f3a3,
title = "Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation",
abstract = "Protein aggregation into amyloid fibrils is a ubiquitous phenomenon across the spectrum of neurodegenerative disorders and type 2 diabetes. A common strategy against amyloidogenesis is to minimize the populations of toxic oligomers and protofibrils by inhibiting protein aggregation with small molecules or nanoparticles. However, melanin synthesis in nature is realized by accelerated protein fibrillation to circumvent accumulation of toxic intermediates. Accordingly, we designed and demonstrated the use of star-shaped poly(2-hydroxyethyl acrylate) (PHEA) nanostructures for promoting aggregation while ameliorating the toxicity of human islet amyloid polypeptide (IAPP), the peptide involved in glycemic control and the pathology of type 2 diabetes. The binding of PHEA elevated the β-sheet content in IAPP aggregates while rendering a new morphology of {"}stelliform{"} amyloids originating from the polymers. Atomistic molecular dynamics simulations revealed that the PHEA arms served as rodlike scaffolds for IAPP binding and subsequently accelerated IAPP aggregation by increased local peptide concentration. The tertiary structure of the star nanoparticles was found to be essential for driving the specific interactions required to impel the accelerated IAPP aggregation. This study sheds new light on the structure-toxicity relationship of IAPP and points to the potential of exploiting star polymers as a new class of therapeutic agents against amyloidogenesis.",
author = "Pilkington, {Emily H} and May Lai and Xinwei Ge and Stanley, {William J} and Bo Wang and Miaoyi Wang and Aleksandr Kakinen and Mark-Antoine Sani and Whittaker, {Michael R} and Gurzov, {Esteban N.} and Feng Ding and John Quinn and Davis, {Thomas P} and Ke, {Pu Chun}",
year = "2017",
month = "12",
day = "11",
doi = "10.1021/acs.biomac.7b01301",
language = "English",
volume = "18",
pages = "4249--4260",
journal = "Biomacromolecules",
issn = "1525-7797",
publisher = "American Chemical Society (ACS)",
number = "12",

}

Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation. / Pilkington, Emily H; Lai, May; Ge, Xinwei; Stanley, William J; Wang, Bo; Wang, Miaoyi; Kakinen, Aleksandr; Sani, Mark-Antoine ; Whittaker, Michael R; Gurzov, Esteban N.; Ding, Feng; Quinn, John; Davis, Thomas P; Ke , Pu Chun .

In: Biomacromolecules, Vol. 18, No. 12, 11.12.2017, p. 4249-4260.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation

AU - Pilkington, Emily H

AU - Lai, May

AU - Ge, Xinwei

AU - Stanley, William J

AU - Wang, Bo

AU - Wang, Miaoyi

AU - Kakinen, Aleksandr

AU - Sani, Mark-Antoine

AU - Whittaker, Michael R

AU - Gurzov, Esteban N.

AU - Ding, Feng

AU - Quinn, John

AU - Davis, Thomas P

AU - Ke , Pu Chun

PY - 2017/12/11

Y1 - 2017/12/11

N2 - Protein aggregation into amyloid fibrils is a ubiquitous phenomenon across the spectrum of neurodegenerative disorders and type 2 diabetes. A common strategy against amyloidogenesis is to minimize the populations of toxic oligomers and protofibrils by inhibiting protein aggregation with small molecules or nanoparticles. However, melanin synthesis in nature is realized by accelerated protein fibrillation to circumvent accumulation of toxic intermediates. Accordingly, we designed and demonstrated the use of star-shaped poly(2-hydroxyethyl acrylate) (PHEA) nanostructures for promoting aggregation while ameliorating the toxicity of human islet amyloid polypeptide (IAPP), the peptide involved in glycemic control and the pathology of type 2 diabetes. The binding of PHEA elevated the β-sheet content in IAPP aggregates while rendering a new morphology of "stelliform" amyloids originating from the polymers. Atomistic molecular dynamics simulations revealed that the PHEA arms served as rodlike scaffolds for IAPP binding and subsequently accelerated IAPP aggregation by increased local peptide concentration. The tertiary structure of the star nanoparticles was found to be essential for driving the specific interactions required to impel the accelerated IAPP aggregation. This study sheds new light on the structure-toxicity relationship of IAPP and points to the potential of exploiting star polymers as a new class of therapeutic agents against amyloidogenesis.

AB - Protein aggregation into amyloid fibrils is a ubiquitous phenomenon across the spectrum of neurodegenerative disorders and type 2 diabetes. A common strategy against amyloidogenesis is to minimize the populations of toxic oligomers and protofibrils by inhibiting protein aggregation with small molecules or nanoparticles. However, melanin synthesis in nature is realized by accelerated protein fibrillation to circumvent accumulation of toxic intermediates. Accordingly, we designed and demonstrated the use of star-shaped poly(2-hydroxyethyl acrylate) (PHEA) nanostructures for promoting aggregation while ameliorating the toxicity of human islet amyloid polypeptide (IAPP), the peptide involved in glycemic control and the pathology of type 2 diabetes. The binding of PHEA elevated the β-sheet content in IAPP aggregates while rendering a new morphology of "stelliform" amyloids originating from the polymers. Atomistic molecular dynamics simulations revealed that the PHEA arms served as rodlike scaffolds for IAPP binding and subsequently accelerated IAPP aggregation by increased local peptide concentration. The tertiary structure of the star nanoparticles was found to be essential for driving the specific interactions required to impel the accelerated IAPP aggregation. This study sheds new light on the structure-toxicity relationship of IAPP and points to the potential of exploiting star polymers as a new class of therapeutic agents against amyloidogenesis.

UR - http://www.scopus.com/inward/record.url?scp=85038215991&partnerID=8YFLogxK

U2 - 10.1021/acs.biomac.7b01301

DO - 10.1021/acs.biomac.7b01301

M3 - Article

VL - 18

SP - 4249

EP - 4260

JO - Biomacromolecules

JF - Biomacromolecules

SN - 1525-7797

IS - 12

ER -